Express interest in being contacted with more details

Please complete this Contact Information.

*Required fields


A Celebration of Innovation

The Prix Galien honors innovation and achievement in the biopharmaceutical and medical device fields.  The award is widely recognized as the equivalent of the Nobel Prize for our industry.

The strength of our industry is in developing innovative therapies and treatments that address unmet medical needs.  Companies like yours have recently pioneered breakthrough treatments with world-class research.  Many of these products offer major advances in treatments over existing options, making the world a better place for patients. 

Our award honors the dedication and hard work of those involved in the difficult task of bringing these new treatments to the market.  In many respects this award is a celebration of innovation in our industry. 

Your company has demonstrated its commitment to innovation by having received marketing approval in the UK by December 31, 2021, but not more than five years earlier than December 31 of that year (unless the award is for a new/ innovative indication added within the past five years).

We ask that you consider recognizing the accomplishments of those in your organization responsible for this achievement by nominating your drug or device for this year’s Prix Galien.

Awards are bestowed in the categories of Best Pharmaceutical Product, Best Biotechnology Product, Best Medical Technology and Best Digital Health.  The committee, comprised of an unrivaled network of Top biomedical scientists including Nobel Laureates in medicine, carefully reviews each submission.  Winners will be announced at our annual award ceremony in London on May 12th, 2022.